An in vitro study proved that the Z. morio hemolymph can reduce the expression of pro-inflammatory factors, including interleukin-1β (IL-1β) and interleukin-18 (IL-18) [17], which suggests that Z. morio hemolymph can be used as a novel therapeutic drug to reduce pathogen infection in animals. Here, IL18 is linked to infection.